fig3
From: Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience
![Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience](https://image.oaes.cc/35ea7333-b66c-4630-9a7a-d1d185f962d7/2850.fig.3.png)
Figure 3. Kaplan-Meier survival analysis of patients with advanced hepatocellular carcinoma (endolympahtic immunotherapy vs. control group) (P < 0.0001)